NCT04723693View on ClinicalTrials.gov

An Exploration of the Impact of Emicizumab on the Lives of People With Haemophilia and Inhibitors and Their Families

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

February 28, 2020

Primary Completion Date

January 31, 2021

Study Completion Date

January 31, 2021

Conditions
Hemophilia A With Inhibitor
Interventions
OTHER

Qualitative Interview

A single one hour semi structured qualitative interview

Trial Locations (1)

OX3 7LE

Oxford University Hospitals NHS Foundation Trust, Oxford

Sponsors

Lead Sponsor

Haemnet
All Listed Sponsors
collaborator

Roche Chugai

INDUSTRY

lead

Haemnet

OTHER

NCT04723693 - An Exploration of the Impact of Emicizumab on the Lives of People With Haemophilia and Inhibitors and Their Families | Biotech Hunter | Biotech Hunter